Announced Thu, 20 Aug · 17:34 IST
Newspaper publication of audited Q4 and FY26 results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.0%1-day move
₹7.81
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+1.0-0.9+1.7+2.2+1.9-3.6+31.1+14.0——
Up moveDown movePending
AI summary
Indrayani Biotech has published its audited financial results for Q4 and full year ended March 31, 2026 in Trinity Mirror (English) and Makkal Kural (Tamil) newspapers on August 20, 2026, as required by SEBI LODR Regulation 47. The board had earlier approved the standalone and consolidated results on August 17, 2026. Results are also available on the company website.
Likely market impact
Routine compliance filing. No new financial details beyond what was already disclosed when results were approved on August 17, 2026.